SLC5A2 and heart failure: In individuals with heart failure with reduced ejection fraction, a comprehensive treatment regime (including ARNI, beta-blockers, MRA, and SGLT2 inhibitors) compared to a conventional regime (ACEi or ARB and beta blockers) reduced the hospital admissions for heart failure by more than two thirds, all-cause mortality by almost half51.